| Latest | Forecast | |
|---|---|---|
| Div Yield | n/a | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | -950.0% |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | n/a | 0.0 |
| PEG | n/a | -999,999.0 |
| Price / Revenue | n/a | 8.5 |
| Price / Book value | n/a |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | n/a | -3.17 | -2.07p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-03-31 | 0.19 | -3.21 | -1.82p | -4.1 | 0.0 | n/a | n/a | 0.0% |
| 2022-03-31 | n/a | -3.17 | -0.99p | -3.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-03-31 | 0.44 | -5.01 | -1.47p | -2.5 | 0.0 | n/a | n/a | 0.0% |
| Evgen upbeat on start of glioblastoma research project Sharecast News | 26 Oct |
|---|
| Change of Name | 25-Apr-24 15:47 |
|---|---|
| Holding(s) in Company | 22-Apr-24 10:12 |
| Holding(s) in Company | 11-Apr-24 22:40 |
| Holding(s) in Company | 09-Apr-24 22:56 |
| Holding(s) in Company | 08-Apr-24 22:44 |